Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• A multiple ascending dose, phase1b study to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics of lesigercept, a long-acting IgE(Trap)-Fc fusion protein, in participants with atopy or allergic diseases1 passage
• Acute kidney injury associated with immune checkpoint inhibitors: A pharmacovigilance study1 passage
• COVID-19-Associated acute respiratory distress syndrome (CARDS): Mechanistic insights on therapeutic intervention and emerging trends1 passage
• Cyclosporine or methotrexate, which one is more promising in the treatment of lichen planopilaris?; A comparative clinical trial1 passage
• Effect of delayed antibiotic use on mortality outcomes in patients with sepsis or septic shock: A systematic review and meta-analysis1 passage
• Effects of melatonin against acute kidney injury: A systematic review and meta-analysis1 passage
• Efficacy and safety of Chinese herbal compound in the treatment of acute gouty arthritis: A systematic review and meta-analysis of randomized controlled trials1 passage
• Efficacy and safety of intranasal corticosteroids combined with mucoactive drugs for chronic rhinosinusitis1 passage
• Immune-related adverse events associated with first-line immune checkpoint inhibitors for metastatic renal cell carcinoma: A systematic review and network meta-analysis1 passage
• Safety, Tolerability, Pharmacokinetics, and pharmacodynamics of YH35324, a novel Long-Acting High-Affinity IgE(Trap)-Fc protein in subjects with Atopy: Results from the First-in-Human study1 passage
• The predictive value of tumor mutation burden on survival of gastric cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis1 passage